Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Protheragen-ING Provides Comprehensive Microneedle Technology Solutions to Achieve Enhanced Drug Delivery Systems

In today’s evolving pharmaceutical landscape, the search for new drug delivery systems (DDS) is of paramount importance to improving therapeutic outcomes. With cutting-edge solutions in the field of microneedle technology, Protheragen-ING is on the front lines in this field. As a certified ISO9001 supplier of pharmaceutical ingredients and specialty chemicals, Protheragen-ING keeps innovating to meet the latest market demand.

Utilizing micron-sized needles to administer drugs directly into the skin, the microneedle technology has become a revolutionary tech in the delivery of drugs. It is not only highly bioavailable, but also has low side effects. With Protheragen-ING’s microneedle technology, controlled drug delivery can be achieved using precise and efficient use of both hollow and solid structures made from any materials (silicons, metals or biodegradable polymers).

The use of microneedles in transdermal drug delivery is much better than other methods, such as hypodermic needles and topical creams. With microneedles drilling down into the stratum corneum, it’s less invasive and more painless than ever before for injecting vaccines, hormones and other medications.

Protheragen-ING can support customers in all phases of microneedle development. From concept to prototyping to manufacture, Protheragen-ING tailors its processes to the unique therapeutic requirements of different sectors. The firm provides various microneedle technology services, such as:

  • Coated Microneedle Development: For drug protection and release control.
  • Dissolving Microneedle Development: Biological alternatives that suck up into the skin and deliver the drug payload to the surface.
  • Hollow Microneedle Development: Ideal for delivery of a liquid drug with a precise dose.
  • Hydrogel Forming Microneedle Development: For longer term release applications.
  • Solid Microneedle Development: Used for perforation and first drug infusion.
  • Integrated Drug Delivery Solutions

Apart from microneedle services, Protheragen-ING is also deeply involved in several novel drug delivery systems.

  • Oral Thin Films: Fast dissolving method to make patient’s compliance easy by giving easy to use.
  • Microencapsulation Systems: Guarding actives and allowing for controlled release.
  • Nanoparticle Development: Solubility enhancement, tissue specificity to get best result from treatment.
  • Vesicular Systems Engineering: Liposomal and niosomal formulations with enhanced stability and release characteristics.
  • Etc.

Protheragen-ING never stops tinkering with drug delivery systems. With a breadth of knowledge in formulation design, material choice, and process and manufacturing optimization, this company has become an unbeatable resource for pharma companies and research groups looking for new solutions to the challenges of today’s drug therapies.

About Protheragen-ING

As the field evolves, Protheragen-ING’s investment in R&D keeps it at the forefront of drug delivery technology. Its emphasis on improving the quality of life for patients using cutting edge technology and custom-fitted solutions speaks to their commitment to changing the face of drugs.

Media Contact

Name
Protheragen-ING
Contact name
Amy George
State
New York
Country
United States
Url
https://www.protheragen-ing.com/

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.